NCT04672096View on ClinicalTrials.gov

Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 4, 2020

Primary Completion Date

May 21, 2021

Study Completion Date

May 21, 2021

Conditions
Chronic Lower Limb Pain
Interventions
DEVICE

Neuronoff BASMATI Injectrode

The 28 day temporary placement of a Basmati Injectrode does not result in unexpected levels of inflammation or encapsulation.

Trial Locations (1)

45458

Ohio Pain Clinic, Dayton

Sponsors

Lead Sponsor

Neuronoff, Inc
All Listed Sponsors
collaborator

Ohio Pain Clinic

OTHER

lead

Neuronoff, Inc

INDUSTRY

NCT04672096 - Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode | Biotech Hunter | Biotech Hunter